Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2015

These securities consist of the following (in thousands):


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2015		2014		2015		2014
Outstanding stock options		19,711		17,336		19,711		17,336
Warrant to purchase common stock		200		200		200		200
Purchase Plan		78		103		78		103

		19,989		17,639		19,989		17,639